Melissa Davoust

Melissa Davoust

Auto-generated profile, based on publicly available information

Melissa Davoust

Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2020 in Journal of HIV/AIDS & Social Services
Verified
Journal Article
Closed access
MDMari-Lynn Drainoni
Mari-Lynn Drainoni
ABAllyson L. Baughman
Allyson L. Baughman
SBSara S. Bachman
Sara S. Bachman
RBRachel Bowers-Sword
Rachel Bowers-Sword
MDMelissa Davoust
Melissa Davoust
LMLinda Sprague Martinez
Linda Sprague Martinez
Objectives: To assess the impact of a Community Health Worker (CHW) intervention within HIV primary care on patient outcomes. Methods: We evaluated a 10-site initiative integrating CHWs into HIV care, examining changes in three outcomes: viral load suppression, a prescription for ART, and appointment attendance. We also assessed the relationship between the three outcomes and the number of CHW encounters. Results: Of 397 participants, most were male and African-American. The mean days of encounters over the first 6 months was 11 per participant. All outcomes improved in the first 6 months: percent with a primary care visit from 49.9 to 84.7% (p < .000); percent with an active ART prescription from 66.9 to 91.3% (p < .000); percent virally suppressed from 22.4 to 43.7% (p < .000). No statistically significant relationship between number of encounters and improvement in outcomes was found. Conclusions: CHW interventions in HIV primary care can lead to improvements in HIV outcomes.

2 February 2021 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MDMelissa Davoust
Melissa Davoust
VGValerie Grim
Valerie Grim
AHAllie Hunter
Allie Hunter
DJDavid K. Jones
David K. Jones
DRDavid Rosenbloom
David Rosenbloom
MDMari-Lynn Drainoni
Mari-Lynn Drainoni

9 August 2021 in AIDS Patient Care and STDs
Verified
Journal Article
Closed access
MDMelissa Davoust
Melissa Davoust
MDMari-Lynn Drainoni
Mari-Lynn Drainoni
ABAllyson Baughman
Allyson Baughman
MRMaria Campos Rojo
Maria Campos Rojo
TETerry Estes
Terry Estes
LMLinda Sprague Martinez
Linda Sprague Martinez
Community health workers (CHWs) are members of the frontline health workforce who serve as intermediaries between health services and communities. In the United States, the role of CHWs has begun to expand as they have been shown to improve outcomes and reduce inequities in care for chronic conditions. This study used qualitative methods to explore the experiences of clients in CHW programs to inform their implementation in HIV care. Thirty clients from 6 Ryan White HIV/AIDS Program care settings across the United States participated in individual semistructured interviews to learn more about their experiences working with a CHW. Four key themes arose from the client perspective. First, CHWs embodied key qualities. Some of the qualities clients attributed to CHWs included being caring and supportive, along with capable of fostering personal connections. Second, CHWs met clients where they were. Clients described the CHW approach as more holistic compared with other care team members; they emphasized CHWs were able to focus on whatever was needed in that moment. Third, CHWs occupied a unique role in the HIV care team. Clients noted CHWs had more time to dedicate to their interactions; they also saw CHWs as representing a different level of authority. Finally, CHWs influenced how clients engaged with care and accessed resources. This included empowering clients to access resources independently in the future. Overall, clients' perceptions of CHWs in terms of their qualities, approach, role, and influence on the HIV care experience suggest they are a valuable resource on the care team.

17 July 2019 in Trials
Verified
Journal Article
Open access
PDF file
LMLarissa Jennings Mayo-Wilson
Larissa Jennings Mayo-Wilson
NGNancy Glass
Nancy Glass
FSFred. M. Ssewamala
Fred. M. Ssewamala
SLSebastian Linnemayr
Sebastian Linnemayr
JCJessica Coleman
Jessica Coleman
Carl LatkinCarl Latkin
Carl Latkin
Economic vulnerability, such as homelessness and unemployment, contributes to the HIV risk among racial minorities in the U.S., who are disproportionately infected. Yet, few economic-strengthening interventions have been adapted for HIV prevention in economically-vulnerable African-American young adults. Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) is a feasibility randomized clinical trial of an HIV prevention microenterprise intervention with integrated text messages (“nudges”) that are informed by behavioral economic principles. The trial aims to reduce sexual risk behaviors and increase employment and uptake of HIV preventive behaviors. In total, 40 young adults who are African-American, aged 18–24, live in Baltimore City, have experienced at least one episode of homelessness in the last 12 months, are unemployed or underemployed (fewer than 10 h per week), are not enrolled in school, own a cell phone with text messaging, and report at least one episode of unprotected or unsafe sex in the prior 12 months will be recruited from two community-based organizations providing residential supportive services to urban youth. Participants will undergo a 3-week run-in period and thereafter be randomly assigned to one of two groups with active interventions for 20 weeks. The first group (“comparison”) will receive text messages with information on job openings. The second group (“experimental”) will receive text messages with information on job openings plus information on HIV prevention and business educational sessions, a mentored apprenticeship, and a start-up grant, and business and HIV prevention text messages based on principles from behavioral economics. The two primary outcomes relate to the feasibility of conducting a larger trial. Secondary outcomes relate to employment, sexual risk behaviors, and HIV preventive practices. All participants will be assessed using an in-person questionnaire at pre-intervention (prior to randomization) and at 3 weeks post-intervention. To obtain repeated, longitudinal measures, participants will be assessed weekly using text message surveys from pre-intervention up to 3 weeks post-intervention. This study will be one of the first U.S.-based feasibility randomized clinical trials of an HIV prevention microenterprise intervention for economically-vulnerable African-American young adults. The findings will inform whether and how to conduct a larger efficacy trial for HIV risk reduction in this population. ClinicalTrials.gov, NCT03766165 . Registered on 4 December 2018.

10 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LMLarissa Jennings Mayo-Wilson
Larissa Jennings Mayo-Wilson
MMMuthoni Mathai
Muthoni Mathai
GYGrace Yi
Grace Yi
MMMargaret O. Mak’aNyengo
Margaret O. Mak’aNyengo
MDMelissa Davoust
Melissa Davoust
NGNAHEDO Study Group
NAHEDO Study Group
Respondent-driven sampling (RDS) is a peer-referral sampling methodology used to estimate characteristics of underserved groups that cannot be randomly sampled. RDS has been implemented in several settings to identify hidden populations at risk for HIV, but few studies have reported the methodological lessons learned on RDS design and implementation for assessing sexual risk behaviors in marginalized youth. We used RDS to recruit N = 350 young adults, aged 18 to 22, who were living in urban slum settlements in Nairobi, Kenya. A structured survey was used to assess sexual risk behaviors. Twenty seeds were selected and asked to recruit up to three eligible peers. We used small monetary incentives and a three-day recruitment coupon with sequential numbers linking recruiters to their recruits. Data collection was completed in 8 days with a maximum chain length of 6 waves. Each seed yielded 16 to 21 eligible recruits. Three (15%) seeds were unproductive and were replaced. RDS benefits were high identification rates (90% coupons returned per coupons given), high eligibility rates (100% eligible recruits per coupons returned), and high efficiency (~39 eligible recruits per day). 44% of the sample was female. Most recruits (74%) reported being “friends” for 7+ years with their recruiter. RDS overcame feasibility concerns of household-, clinic-, and school-based sampling methodologies in that underserved youth who were unemployed (68%), out of school (48%), ethnic minorities (26%), and having prior residential instability (≥2 moves in the past year) (20%) were successfully recruited, based on weighted analyses. Youth reporting HIV risk behaviors, including unprotected sex (38%), sex while high/drunk (35%), and sex exchange for pay (14%), were also enrolled. However, 28% were not sexually active within the last 6 months. Challenges included managing wait times during peaks and participant referral expectations. Community engagement, use of study-stamped coupons, broad inclusion criteria, incentives, and study sites within walking distances all contributed to the successful implementation of the sampling methodology. RDS is an important tool in reaching a diverse sample of underserved and at-risk young adults for study participation. Implications for optimizing RDS for behavioral studies in this population are discussed.

4 March 2025 in Addiction Science & Clinical Practice
Verified
Journal Article
Open access
PDF file
MDMelissa Davoust
Melissa Davoust
ABAngela R. Bazzi
Angela R. Bazzi
SBSamantha Blakemore
Samantha Blakemore
JBJuliana Blodgett
Juliana Blodgett
ACAnna Cheng
Anna Cheng
ZWZoe M. Weinstein
Zoe M. Weinstein
Background: Deaths from opioid overdose have increased dramatically in the past decade. For individuals with opioid use disorder (OUD), agonist medications such as methadone and buprenorphine reduce opioid-related morbidity and mortality. Historically, the provision of buprenorphine treatment in office-based settings has relied on frequent in-person contact, likely influencing patients’ access to and retention in care. In response to the COVID-19 pandemic, providers of office-based buprenorphine treatment rapidly adapted their care processes, increasingly relying on telemedicine visits. To date, relatively few prior studies have combined patient and clinician perspectives to examine the implementation of telemedicine and related care adaptations, particularly in safety-net settings. Methods: Qualitative methods were used to explore clinician and patient experiences with telemedicine in an office-based buprenorphine treatment clinic affiliated with an urban safety-net hospital. From this clinic, we conducted semi-structured interviews with 25 patients and 16 clinicians (including prescribers and non-prescribers). We coded all interview data and used a thematic analysis approach to understand how telemedicine impacted treatment quality and engagement in care, as well as preferences for using telemedicine moving forward. Results: Five themes regarding the implementation of telemedicine and other COVID-19-related care adaptations arose from patient and clinician perspectives: (1) telemedicine integration precipitated openness to more flexibility in care practices, (2) concerns regarding telemedicine-related adaptations centered around safety and accountability, (3) telemedicine encounters required rapport and trust between patients and clinicians to facilitate open communication, (4) safety-net patient populations experienced unique challenges when using telemedicine, particularly in terms of the technology required and the need for privacy, and (5) there is an important role for telemedicine in office-based buprenorphine treatment moving forward, primarily through its use in hybrid models of care which integrate both in-person and virtual visits. Conclusions: Telemedicine implementation within office-based buprenorphine treatment has the potential to improve patients’ engagement in care; however, our findings emphasize the need for tailored approaches to implementing telemedicine in office-based buprenorphine treatment, particularly within safety-net settings. Overall, this study supports the maintenance of changes to policy and practice that facilitate the use of telemedicine in office-based buprenorphine treatment beyond the COVID-19 public health emergency.